Trial Profile
Retrospective cohort study comparing clinical outcomes of Tofacitinib versus Adalimumab and Etanercept therapy in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Adalimumab; Etanercept
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record